Alterity.png
Alterity’s ATH434 Prevents Loss of Brain Cells in Parkinson’s Disease Animal Model
30 janv. 2023 07h25 HE | ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
Explora BioLabs Launches Turnkey Preclinical Vivariums in Seattle
Explora BioLabs Launches Preclinical Vivarium Model in Seattle
24 janv. 2022 11h00 HE | Explora BioLabs
SEATTLE, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Explora BioLabs, the national provider of industry-leading preclinical vivarium research space and management services headquartered in San Diego, recently...
Biotherapharma_logo.jpg
Preclinical Data Showing Synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone Symposia
26 mars 2018 10h00 HE | Biothera Pharmaceuticals, Inc.
EAGAN, Minn., March 26, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. and the Abramson Cancer Center of the University of Pennsylvania announced today the presentation of new preclinical...
Biotherapharma_logo.jpg
Biothera Pharmaceuticals Presents Data Broadening Imprime PGG Mechanism of Action
13 nov. 2017 09h30 HE | Biothera Pharmaceuticals, Inc.
Reduces expression of IDO, a potent suppressor of an anti-cancer T cell response Supplementation with IVIG boosts biomarker levels, restoring Imprime-driven pharmacodynamic responses EAGAN, Minn.,...
Biotherapharma_logo.jpg
Biothera Pharmaceuticals Presents Preclinical Data Showing Imprime PGG Activates Natural Killer Cell-Mediated Tumor Killing
30 oct. 2017 09h00 HE | Biothera Pharmaceuticals, Inc.
EAGAN, Minn., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. announced today the presentation of new preclinical findings showing that the Company’s Phase 2 cancer immunotherapy...
Biotherapharma_logo.jpg
Biothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual Meeting
27 mars 2017 11h00 HE | Biothera Pharmaceuticals, Inc.
EAGAN, Minn., March 27, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals Inc. announced today that it will present three scientific posters at the American Association for Cancer Research (AACR)...